Open Medicine
(Sep 2019)
The factors affecting early death in newly diagnosed APL patients
Ciftciler Rafiye,
Haznedaroglu Ibrahim Celalettin,
Aksu Salih,
Ozcebe Osman,
Sayınalp Nilgun,
Malkan Umit Yavuz,
Buyukasık Yahya
Affiliations
Ciftciler Rafiye
Hacettepe University Faculty of Medicine, Department of Hematology; Ankara, Turkey
Haznedaroglu Ibrahim Celalettin
Hacettepe University Faculty of Medicine, Department of Hematology; Ankara, Turkey
Aksu Salih
Hacettepe University Faculty of Medicine, Department of Hematology; Ankara, Turkey
Ozcebe Osman
Hacettepe University Faculty of Medicine, Department of Hematology; Ankara, Turkey
Sayınalp Nilgun
Hacettepe University Faculty of Medicine, Department of Hematology; Ankara, Turkey
Malkan Umit Yavuz
Dıskapı Education and Research Hospital, Department of Hematology, Ankara, Turkey
Buyukasık Yahya
Hacettepe University Faculty of Medicine, Department of Hematology; Ankara, Turkey
DOI
https://doi.org/10.1515/med-2019-0074
Journal volume & issue
Vol. 14,
no. 1
Abstract
Read online
In the past, acute promyelocytic leukemia (APL) was considered as one of the most rapidly lethal form of acute myeloid leukemia (AML). The objective of this study was to assess clinical parameters affecting early death (ED) in patients with APL.
Keywords
WeChat QR code
Close
